Literature DB >> 25135176

Liver-to-spleen ratio as an index of chronic liver diseases and safety of hepatectomy: a pilot study.

Yangqing Huang1, Bin Huang, Tong Kan, Boshuai Yang, Min Yuan, Jiefei Wang.   

Abstract

BACKGROUND: Hepatic failure is a main cause of death after hepatectomy. Accurate preoperative evaluation of functional liver reserve is the key to ensure safe resection. Studies have found that the spleen would gradually enlarge as chronic liver disease worsened. This study was designed to determine whether preoperative liver-to-spleen ratio (LSR) would be an indicator to evaluate severity of liver disease and predict safety of hepatectomy.
METHODS: The volumes of liver and spleen were evaluated on computed tomography scan in 67 patients who received partial hepatectomy. Preoperative LSR was calculated. Statistical analysis was conducted to examine the relationship between LSR and the degree of chronic liver disease. Ability of LSR to predict the safety of hepatectomy also was evaluated.
RESULTS: LSR had a negative correlation with the degree of chronic liver diseases (r = -0.606, P < 0.0001). LSR = 3.22 was the cutoff point for predicting posthepatectomy complications and inadequacy. AUC, sensitivity, and specificity for predicting posthepatectomy complications and inadequacy respectively were 0.830 (95 % confidence interval [CI] 0.715-0.950, P < 0.0001), 69.6, 93.2 %, and 0.863 (95 % CI 0.777-0.949, P < 0.0001), 68.8, 84.3 %. Multivariate analysis showed that LSR = 3.22 was the factor that affected both posthepatectomy complications and liver inadequacy.
CONCLUSIONS: Preoperative LSR score correlated well with the degree of chronic liver diseases, and it probably help us to improve the safety of hepatectomy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25135176     DOI: 10.1007/s00268-014-2717-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

1.  [Serial hepatic and splenic volumetry in acute severe hepatitis].

Authors:  M Obuchi; M Yoshiba; K Sekiyama; M Homda; K Takizawa; K Uchiyama; K Doai; Y Kuniyasu
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1999-02

2.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

4.  Remnant liver volume to body weight ratio > or =0.5%: A new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver.

Authors:  Stéphanie Truant; Olivier Oberlin; Géraldine Sergent; Gilles Lebuffe; Luc Gambiez; Olivier Ernst; François-René Pruvot
Journal:  J Am Coll Surg       Date:  2006-11-16       Impact factor: 6.113

5.  Assessment of hepatic reserve for indication of hepatic resection: how I do it.

Authors:  Ronnie T Poon; Sheung Tat Fan
Journal:  J Hepatobiliary Pancreat Surg       Date:  2005

6.  Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate.

Authors:  Yasuhiro Ogawa; Yoriko Murata; Toshiji Saibara; Akihito Nishioka; Shinji Kariya; Shoji Yoshida
Journal:  Oncol Rep       Date:  2003 Sep-Oct       Impact factor: 3.906

7.  Liver failure following partial hepatectomy.

Authors:  Thomas S Helling
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

8.  Prognostic value of the monoethylglycinexylidide (MEGX)-test prior to liver resection.

Authors:  T Lorf; A A Schnitzbauer; S K H Schaefers; M N Scherer; H J Schlitt; M Oellerich; H Becker; A Obed
Journal:  Hepatogastroenterology       Date:  2008 Mar-Apr

9.  Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study.

Authors:  Alessandro Ferrero; Luca Viganò; Roberto Polastri; Andrea Muratore; Haris Eminefendic; Daniele Regge; Lorenzo Capussotti
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

Review 10.  Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment.

Authors:  Maartje A J van den Broek; Steven W M Olde Damink; Cornelis H C Dejong; Hauke Lang; Massimo Malagó; Rajiv Jalan; Fuat H Saner
Journal:  Liver Int       Date:  2008-07       Impact factor: 5.828

View more
  4 in total

1.  CT-scan Based Liver and Spleen Volume Measurement as a Prognostic Indicator for Patients with Cirrhosis.

Authors:  Milan Patel; Mark Tann; Suthat Liangpunsakul
Journal:  Am J Med Sci       Date:  2020-11-02       Impact factor: 3.462

2.  Predictive power of splenic thickness for post-hepatectomy liver failure in HBV-associated hepatocellular carcinoma patients.

Authors:  Xiang Chen; Heng Zou; Li Xiong; Sheng-Fu Huang; Xiong-Ying Miao; Yu Wen
Journal:  World J Surg Oncol       Date:  2017-12-04       Impact factor: 2.754

3.  Improvement of non-alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients.

Authors:  Yuichi Endo; Masayuki Ohta; Kazuhiro Tada; Hiroaki Nakanuma; Kunihiro Saga; Takashi Masuda; Teijiro Hirashita; Yukio Iwashita; Yoshinori Ozeki; Takayuki Masaki; Masafumi Inomata
Journal:  Ann Gastroenterol Surg       Date:  2019-01-29

4.  The technique of 3D reconstruction combining with biochemistry to build an equivalent formula of indocyanine green (ICG) clearance test to assess the liver reserve function.

Authors:  Jinli Zheng; Wei Xie; Yang Huang; Yunfeng Zhu; Li Jiang
Journal:  BMC Surg       Date:  2020-11-12       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.